HomeCompareFRES vs GBDC

FRES vs GBDC: Dividend Comparison 2026

FRES yields 235.29% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRES wins by $294.76M in total portfolio value
10 years
FRES
FRES
● Live price
235.29%
Share price
$0.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$315.61M
Annual income
$171,899,209.13
Full FRES calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — FRES vs GBDC

📍 FRES pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRESGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRES + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRES pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRES
Annual income on $10K today (after 15% tax)
$20,000.00/yr
After 10yr DRIP, annual income (after tax)
$146,114,327.76/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, FRES beats the other by $132,131,204.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRES + GBDC for your $10,000?

FRES: 50%GBDC: 50%
100% GBDC50/50100% FRES
Portfolio after 10yr
$168.23M
Annual income
$94,174,971.49/yr
Blended yield
55.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

FRES
Analyst Ratings
1
Buy
Consensus: Buy
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRES buys
0
GBDC buys
0
No recent congressional trades found for FRES or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRESGBDC
Forward yield235.29%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$315.61M$20.85M
Annual income after 10y$171,899,209.13$16,450,733.83
Total dividends collected$299.93M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: FRES vs GBDC ($10,000, DRIP)

YearFRES PortfolioFRES Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$34,229$23,529.41$12,492$1,791.70+$21.7KFRES
2$111,896$75,270.83$16,527$3,160.58+$95.4KFRES
3$349,693$229,963.68$23,588$5,904.90+$326.1KFRES
4$1,045,826$671,655.14$37,141$11,901.65+$1.01MFRES
5$2,996,342$1,877,308.05$66,205$26,463.38+$2.93MFRES
6$8,232,794$5,026,707.34$137,452$66,612.65+$8.10MFRES
7$21,716,990$12,907,901.09$342,372$195,298.53+$21.37MFRES
8$55,058,944$31,821,764.79$1,053,292$686,954.33+$54.01MFRES
9$134,312,616$75,399,545.57$4,111,439$2,984,416.95+$130.20MFRES
10$315,613,708$171,899,209.13$20,849,974$16,450,733.83+$294.76MFRES

FRES vs GBDC: Complete Analysis 2026

FRESStock

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Full FRES Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this FRES vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRES vs SCHDFRES vs JEPIFRES vs OFRES vs KOFRES vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.